PVCT Projected Dividend Yield
Provectus Biopharmaceuticals Inc ( OTCBB : PVCT )Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company. Co. is engaged in developing immunotherapy medicines for different diseases that are based on a class of synthetic small-molecule immuno-catalysts called halogenated xanthenes (HXs). Co.'s lead molecule is named rose bengal sodium (RBS). Co.'s small molecule HX medical science platform comprises a range of different drug product candidates and preclinical pharmaceutical-grade RBS formulations using different concentrations and delivered by different routes of administration specific to each disease area and/or indication. 21 YEAR PERFORMANCE RESULTS |
PVCT Dividend History Detail PVCT Dividend News PVCT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |